CID 2745687 (Standard)
CID 2745687 (Standard) is the analytical standard of CID 2745687 (HY-107537). This product is intended for research and analytical applications. CID 2745687 acts as a specific, reversible and competitive GPR35 antagonist with a Ki of 12.8 nM.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 264233-05-8
- Fòrmula: C17H19F2N5O2S
- Peso molecular:395.43
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-107537
CID 2745687GPR35 Antagonist -
HY-W010907
Pamoic acid disodiumGPR35 Agonist -
HY-107536
ML 145GPR35 Antagonist -
HY-107538
YE120GPR35 Agonist -
HY-107539
GPR35 agonist 4GPR35 Agonist -
HY-15705
GPR35 agonist 2GPR35 Agonist -
HY-B1816
ZaprinastPDE5 Inhibitor -
HY-134801
CID1231538GPR35 Antagonist -
HY-W008613
Pamoic acidGPR35 Agonist -
HY-107536R
ML 145 (Standard)Reference Standard -
HY-106481
BufrolinGPR35 Agonist -
HY-W008613R
Pamoic acid (Standard)GPR35 Agonist
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 264233-05-8
-
Peso molecular 395.43
-
Fòrmula C17H19F2N5O2S
-
SMILES
O=C(C1=C(/C=N/NC(NC(C)(C)C)=S)N(C2=CC=C(C=C2F)F)N=C1)OC
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Pingwei Zhao, et al. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Mol Pharmacol. 2010 Oct;78(4):560-8. [Content Brief]
[2]. Laura Jenkins, et al. Antagonists of GPR35 display high species ortholog selectivity and varying modes of action. J Pharmacol Exp Ther. 2012 Dec;343(3):683-95. [Content Brief]
[3]. Mi-Jeong Kim, et al. Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35. Biomol Ther (Seoul). 2019 Jun 13;28(1):92-97. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CID 2745687 (Standard) Related Classifications
HY-107537R Related Classifications
Powered by Bioz